title: Differentiation of parkinsonian syndromes according to differences in executive functions.
abstract: Groups of patients with Parkinson's disease (PD), striatonigral degeneration-type multiple system atrophy (MSA) or progressive supranuclear palsy (PSP) with motor disability stages II and III according to Hoehn and Yahr, and a healthy control group were compared using neuropsychological tests of executive functions. The results indicate that all three patient groups were impaired in the tests of executive functions. In comparison with healthy subjects, the three patient groups showed impaired performance regarding verbal fluency, problem solving and verbal and figural working memory. Patients with PD differed significantly from healthy subjects in a test of verbal recency, while patients with MSA or PSP were unimpaired. The comparison of patient groups revealed no differences between PD and MSA patients. However, patients with PSP showed greater impairment in both phonemic and semantic fluency than patients with PD or MSA. Using discriminant function analysis, it was found that variables derived from four verbal fluency tasks (simple and alternate semantic and phonemic fluency) discriminated among the three patient groups at a level significantly exceeding chance. Over 90% of patients with PSP were correctly classified. Patients with PD and MSA were correctly classified in over 70% of cases. These results suggest that verbal fluency tasks may be sensitive measures in the differential diagnosis of PD, MSA and PSP.
authors.affiliation: Institute of Experimental Psychology, University of Regensburg, Regensburg, Germany. klaus.lange@psychologie.uni-regensburg.de
authors.forename: K W
authors.initials: KW
authors.lastname: Lange
authors.forename: O
authors.initials: O
authors.lastname: Tucha
authors.forename: G L
authors.initials: GL
authors.lastname: Alders
authors.forename: M
authors.initials: M
authors.lastname: Preier
authors.forename: I
authors.initials: I
authors.lastname: Csoti
authors.forename: B
authors.initials: B
authors.lastname: Merz
authors.forename: G
authors.initials: G
authors.lastname: Mark
authors.forename: B
authors.initials: B
authors.lastname: Herting
authors.forename: F
authors.initials: F
authors.lastname: Fornadi
authors.forename: H
authors.initials: H
authors.lastname: Reichmann
authors.forename: P
authors.initials: P
authors.lastname: Vieregge
authors.forename: K
authors.initials: K
authors.lastname: Reiners
authors.forename: G
authors.initials: G
authors.lastname: Becker
authors.forename: M
authors.initials: M
authors.lastname: Naumann
mesh_terms: D000368:Aged; D003071:Cognition / Q000502:physiology; D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008570:Memory, Short-Term / Q000502:physiology; D008875:Middle Aged; D019578:Multiple System Atrophy / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D013064:Speech Disorders / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D013494:Supranuclear Palsy, Progressive / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D014705:Verbal Behavior / Q000502:physiology